Jean-Luc Treillou

Jean-Luc Treillou is the Chairman at TreeFrog Therapeutics. Jean-Luc has over two decades of experience in the biotech and pharmaceutical industries.

Treillou started their career at eshard, a French biotech company, where they helped develop new treatments for pain relief. Jean-Luc then co-founded TreeFrog Therapeutics, a stem cell company that aims to make cell therapies more accessible and affordable. Through TreeFrog, they have helped secure cell production and quality for numerous cell therapy players, fastened clinical development, and facilitated market access.

Jean-Luc Treillou has a Certificat Administrateur de Sociétés from Sciences Po, a Pharmacist graduation + post graduation in Pharmaceutical Formulation and galenic from UNIVERSITY OF TOURS, and a STEGE Marketing from ESCP EAP business school, Paris.